Man Group plc - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 153 filers reported holding AIMMUNE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.71 and the average weighting 0.4%.

Quarter-by-quarter ownership
Man Group plc ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$26,785,000
+3625.3%
777,492
+2165.8%
0.10%
+3400.0%
Q3 2019$719,000
-56.4%
34,314
-53.5%
0.00%
-50.0%
Q1 2019$1,649,000
+265.6%
73,779
+345.8%
0.01%
+200.0%
Q3 2018$451,000
+202.7%
16,550
+199.0%
0.00%
+100.0%
Q2 2018$149,0005,5360.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 3,967,900$42,933,00029.35%
TLP GROUP LLC 2,833,285$30,656,00020.86%
Aisling Capital LLC 2,990,000$32,352,0007.64%
Vivo Capital, LLC 763,009$8,256,0002.26%
RA Capital Management 1,292,940$13,990,0001.94%
Foresite Capital Management III, LLC 235,020$2,543,0001.74%
Palo Alto Investors LP 325,599$3,523,0000.27%
Rock Springs Capital Management LP 293,000$3,170,0000.24%
EMERALD MUTUAL FUND ADVISERS TRUST 332,625$3,599,0000.20%
Virtus ETF Advisers LLC 19,501$211,0000.16%
View complete list of AIMMUNE THERAPEUTICS INC shareholders